Acquisition - April 22, 2015
Attorney Joins Virtual Management Team
Attorney Stefan Wendén, a managing partner in a Swedish law firm, is now part of the Malmö-based research park Medeons first virtual management team. The new concept is being tested at Richter Life Science Development, founded by Agneta Richter Dahlfors, professor of microbiology at Karolinska Institutet, according to Swedish Life Science. In a virtual management […]
Acquisition - April 21, 2015
Novo Nordisk, Janssen Sign Pact
Novo Nordisk A/S and Janssen Biotech, Inc. have signed an agreement that will allow Janssen to acquire an exclusive global license to further develop and commercialize a clinical program focused on therapy within autoimmune diseases. The program targets modulation of certain immune cells via a cell surface receptor (NKG2D receptor), according to Novo Nordisk. The […]
Acquisition - April 9, 2015
Smart Wise Buys KI Device Rights
The sale of the rights to Karolinska Institutet Innovations AB project Extroducer to the company Smart Wise AB is KI Innovations second major deal in fewer than six months. The device is a microcatheter with unique features that make it possible to deliver drugs directly to hard- to-reach organs. The microcatheter was developed by three researchers in […]
Acquisition - April 7, 2015
Depomed Buys US Rights to Janssen Franchise
Depomed, Inc. has closed the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for $1.05 billion. The NUCYNTA franchise includes NUCYNTA® ER (tapentadol) extended release tablets indicated for the management of pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN), an immediate release version of tapentadol, for management of moderate to severe […]
Acquisition - March 25, 2015
Novo Sells Autoimmune Program
Novo Nordisk has sold one of its early-stage autoimmune research programs to Bristol-Myers Squibb for an undisclosed amount. As part of the agreement, Bristol-Myers obtains the exclusive rights to a discovery-stage biologics program that targets the innate immune system, which is the body’s first line of defense against infection. Novo’s program was striving to treat […]
Acquisition - March 24, 2015
AZ Adopts e-Commerce Platform
Assay Depot, Inc., in conjunction with Astra Zeneca, recently developed and launched a preclinical research e-commerce platform called the AstraZeneca Innovation Marketplace (AIM). The program helps accelerate research and shorten the research cycle by automating legal and administrative processes. “AIM simplifies the purchase of preclinical services from our external partners. It will make our researchers’ […]
